Biomarker Assessment of Venous Thromboembolism in Cancer Patients Receiving Checkpoint Blockade

被引：3
|
作者：
Swaidani, Shadi [1 ,2 ]
Roopkumar, Joanna [3 ]
Jun-Shim, Young [1 ]
Charles, Cathy [1 ]
Paul, Slato [1 ]
Kundu, Suman [1 ]
Funchain, Pauline [3 ]
Rayman, Patricia [2 ]
Pavicic, Paul G. [2 ]
Diaz-Montero, C. Marcela [2 ]
Khorana, Alok A. [3 ]
McCrae, Keith R. [1 ,3 ]
机构：
[1] Cleveland Clin, Cardiovasc & Metab Sci, Cleveland, OH 44106 USA
[2] Cleveland Clin, Inflammat and Immun, Cleveland, OH 44106 USA
[3] Cleveland Clin, Dept Hematol & Med Oncol, Taussig Canc Inst, Cleveland, OH 44106 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-130911
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3648
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Venous thromboembolism events in patients with advanced cancer on immune checkpoint inhibitors
    Kartolo, Adi
    Yeung, Cynthia
    Moffat, Gordon T.
    Hanna, Lilian
    Hopman, Wilma
    Baetz, Tara
    IMMUNOTHERAPY, 2022, 14 (01) : 23 - 30
  • [22] Venous Thromboembolism Risk in Cancer Patients Receiving First-Line Immune Checkpoint Inhibitor Vs. Chemotherapy
    May, Sarah B.
    La, Jennifer
    Milner, Emily
    Riaz, Nimrah
    Amos, Christopher, I
    Garcia, David A.
    Carrier, Marc
    Zakai, Neil
    Do, Nhan, V
    Brophy, Mary
    Chitalia, Vipul
    Gaziano, J. Michael
    Fillmore, Nathanael
    Li, Ang
    BLOOD, 2022, 140 : 7968 - 7970
  • [23] Thromboembolism and Immune Checkpoint Blockade in Cancer Patients: An Old Foe for New Research
    Fontsa, Mireille Langouo
    Aiello, Marco Maria
    Migliori, Edoardo
    Scartozzi, Mario
    Lambertini, Matteo
    Willard-Gallo, Karen
    Solinas, Cinzia
    TARGETED ONCOLOGY, 2022, 17 (05) : 497 - 505
  • [24] Thromboembolism and Immune Checkpoint Blockade in Cancer Patients: An Old Foe for New Research
    Mireille Langouo Fontsa
    Marco Maria Aiello
    Edoardo Migliori
    Mario Scartozzi
    Matteo Lambertini
    Karen Willard-Gallo
    Cinzia Solinas
    Targeted Oncology, 2022, 17 : 497 - 505
  • [25] A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score
    Melina Verso
    Giancarlo Agnelli
    Sandro Barni
    Giampietro Gasparini
    Roberto LaBianca
    Internal and Emergency Medicine, 2012, 7 : 291 - 292
  • [26] Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
    Krabbe, L. -M.
    Krabbe, B.
    UROLOGE, 2017, 56 (10): : 1323 - 1326
  • [27] Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
    Rutjes, Anne W. S.
    Porreca, Ettore
    Candeloro, Matteo
    Valeriani, Emanuele
    Di Nisio, Marcello
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (12):
  • [28] Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
    Di Nisio, Marcello
    Porreca, Ettore
    Otten, Hans-Martin
    Rutjes, Anne W. S.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (08):
  • [29] A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score
    Verso, Melina
    Agnelli, Giancarlo
    Barni, Sandro
    Gasparini, Giampietro
    LaBianca, Roberto
    INTERNAL AND EMERGENCY MEDICINE, 2012, 7 (03) : 291 - 292
  • [30] Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
    Di Nisio, Marcello
    Porreca, Ettore
    Candeloro, Matteo
    De Tursi, Michele
    Russi, Ilaria
    Rutjes, Anne W. S.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (12):
12345